We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry

By LabMedica International staff writers
Posted on 04 Sep 2025

cmef.com.cn/en">The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou. With the theme "Health, Innovation, Collaboration," this major event, organized by Reed Sinopharm Exhibitions (Beijing, China), aims to bring together the global healthcare community to explore fresh opportunities for advancing high-quality development within the industry.

Recognized as a premier international exhibition encompassing the full spectrum of the medical equipment industry, CMEF serves as a global hub for stakeholders to come together and promote healthcare advancement. The event facilitates innovation showcases, strategic partnerships, brand exposure, academic exchanges, insight sharing, and professional training. In 2025, the exhibition will cover nearly 200,000 square meters, drawing approximately 4,000 companies and around 120,000 professionals from across the globe.

This year’s fair will present 28 specialized themed zones, highlighting areas such as medical imaging, in vitro diagnostics, surgical robotics, smart healthcare, and more—providing a comprehensive look at the entire ecosystem, from upstream research and development to final end-user applications. Key focus areas will include innovations in smart technology, enhanced collaboration along the supply chain, integration of international resources, precision medicine, and targeted solutions for aging populations.

More than 60 conferences and forums are planned for CMEF 2025, spanning policy and industry themes. These will cover topics such as healthy living, public hospital reform, medical artificial intelligence, device digitalization, imaging technologies, in vitro diagnostics, rehabilitation and elder care, home healthcare, the silver economy, chronic disease management, emergency response, intelligent health, veterinary medicine, and global regulatory standards. These sessions will feature insights from over 1,000 distinguished experts.

The International Exhibition segment of CMEF 2025 will spotlight leading companies from over 20 countries and regions, including the United States, Singapore, Malaysia, and Germany. Industry association leaders and diplomatic representatives will provide practical insights into medical device export regulations through real-world case studies. Additionally, they will organize targeted networking opportunities and promotional sessions to support international cooperation and technological innovation.

For the first time, CMEF 2025 will introduce the 'International Healthy Lifestyle Fair (IHL)' alongside two major events: the inaugural CMEF Health Promotion Conference and the Healthy Living Carnival. This initiative will serve as a broad, cross-sector platform dedicated to promoting healthy lifestyles, establishing a comprehensive ecosystem that addresses prevention, intervention, and ongoing health management. The approach reflects a distinctly Chinese model of global health promotion—integrating cutting-edge technologies, progressive policy frameworks, and human-centered values.

Tailored for health-conscious consumers and professionals, this initiative brings together aspects of routine healthcare, physical fitness, mental wellness, and sustainable living. It aims to deliver integrated solutions throughout every life stage. With CMEF’s global reach, the showcase will feature more than 1,000 products, including smart wearables, home healthcare technologies, chronic and elderly care devices, intelligent home systems, fitness and beauty tools, traditional Chinese medicine, and pet wellness products—driving forward the accessibility and innovation of healthcare solutions.

The debut of IHL marks CMEF’s evolution from a purely professional industry exhibition to a hybrid platform that merges medical and consumer health innovation. It positions CMEF as a testing ground for public wellness technologies on a global scale. The event will feature advanced medical consumables, such as next-generation, precise, and environmentally friendly solutions for cardiovascular and vascular conditions—covering technologies like percutaneous ventricular assist devices (pVAD), intra-aortic balloon pumps (IABP), enhanced external counterpulsation (EECP) systems, non-invasive cardiac output monitors, naturally derived vascular stents, intracranial photobiomodulation (PBM) devices, and hemostatic closure systems.

Also on display will be medical robotics, including the latest in laparoscopic surgical systems; smart health technologies such as AI-enabled chronic disease management tools, wearable devices, and 5G-enabled remote surgical solutions supporting precision medicine; and breakthroughs in IVD and early screening, including innovations in cancer detection, point-of-care testing (POCT), and molecular diagnostics.

Related Links:
CMEF Visitor Pre-Registration


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.